Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
GHO Capital has acquired a majority stake in Sterling Pharma Solutions, a specialist in complex and difficult to manufacture APIs.
read more
Pii announced the FDA has issued their EIRs for both FEI registration numbers (1000513101/3006503102), covering Pii's facilities in Hunt Valley and Cockeysville, MD.
read more
Walgreens Boots Alliance has named Heather Dixon as its new senior vice president, global controller and chief accounting officer, effective March 18, 2019.
read more
Iktos announced a collaboration agreement with Merck KGaA, Darmstadt, Germany, where Iktos generative modelling AI will be used to facilitate discovery and design of compounds for Merck KGaA.
read more
AbCellera announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research.
read more
Pii has announced the launch of Busulfan Injection, 6mg/mL in 10mL vials, in partnership with Athenex Pharmaceuticals, Sungen Pharma and Chemwerth.
read more
JSR today it will establish a US headquarters for its biotechnology and life sciences focused businesses under the name JSR Life Sciences, LLC effective April 1, 2019.
read more
BioVectra announced a five-year, $144.6 million (CAD) expansion project to enhance its Biopharmaceutical capabilities in both Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
read more
Piramal Critical Care announced the launch of MITIGO™ (Morphine Sulfate Injection, USP – Preservative-free) in 10 mg/mL and 25 mg/mL concentrations in the U.S. market.
read more
SunGen Pharma announced the launch of Busulfan Injection, the second product launch through their joint venture Peterson Athenex with Athenex Pharmaceuticals.
read more
Under this co-exclusive agreement, the Pall Biotech line of business will immediately distribute ARTeSYN's standard hardware and liner components off the shelf.
read more
Novartis has announced Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis on March 31, 2019.
read more
Under a license agreement with the HMRI for development of clinical grade RNA manufacturing services, VGXI announced it has completed all of the partnership’s Phase I initiatives and anticipates Phase II will conclude by 4Q 2019.
read more
C2 PHARMA has acquired the Digoxin API product portfolio of Polish company, Nobilus Ent, self-developed and inherited from Roche/Galenus Mannheim.
read more
Alcami has launched Alcami Biologics, the organization's new biopharmaceutical development, analytical testing, manufacturing, and packaging enterprise.
read more